.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
US Department of Justice
Dow
Colorcon
AstraZeneca
US Army
UBS
Queensland Health
Novartis
Citi

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078717

« Back to Dashboard

NDA 078717 describes ROCURONIUM BROMIDE, which is a drug marketed by Aurobindo Pharma Ltd, Fresenius Kabi Usa, Hospira, Mylan Institutional, Sagent Pharms, Sandoz Inc, Tamarang, Teva Pharms, and West Ward Pharm Corp, and is included in nine NDAs. It is available from eleven suppliers. Additional details are available on the ROCURONIUM BROMIDE profile page.

The generic ingredient in ROCURONIUM BROMIDE is rocuronium bromide. There are eleven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the rocuronium bromide profile page.

Summary for 078717

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 078717

Suppliers and Packaging for NDA: 078717

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ROCURONIUM BROMIDE rocuronium bromide INJECTABLE;INJECTION 078717 ANDA Teva Parenteral Medicines, Inc. 0703-2394 0703-2394-03 10 VIAL, MULTI-DOSE in 1 CARTON (0703-2394-03) > 5 mL in 1 VIAL, MULTI-DOSE (0703-2394-01)
ROCURONIUM BROMIDE rocuronium bromide INJECTABLE;INJECTION 078717 ANDA Teva Parenteral Medicines, Inc. 0703-2395 0703-2395-03 10 VIAL, MULTI-DOSE in 1 CARTON (0703-2395-03) > 10 mL in 1 VIAL, MULTI-DOSE (0703-2395-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength50MG/5ML (10MG/ML)
Approval Date:Nov 26, 2008TE:APRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength100MG/10ML (10MG/ML)
Approval Date:Nov 26, 2008TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Cipla
Farmers Insurance
Novartis
Queensland Health
Moodys
US Army
Teva
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot